Allulose reduces body fat and improves lipid profile in humans
Secondary endpoints: Change in ADCS-ADL-MCI (up to week 104) and time to worsening in CDR (up to week 156)
Moran, Claus Aagaard Nielsen, Mikkel Due Petersen, Lars Nygaard, David rsted, Christian Poulsen, Tina Secher Rasmussen, and Else Marie Agger (Novo Nordisk A/S, Denmark) for review of and input to the manuscript, and to Alexander Jones, PhD, CMPP TM and Sola Neunie, MSc, CMPP TM from AXON Communications (supported by Novo Nordisk) for writing assisstance
\Improved Cholesterol and Triglycerides: Positively affects blood fat levels, including triglycerides and cholesterol ratios
Im quite a bit overweight
Ngo-Hamilton says that without having FDA approval to treat weight loss just Type 2 diabetes its technically off-label use. That means a provider is prescribing a medication to treat something it isnt meant to treat